Brazil stem cell research & development plan drives embryo register:
This article was originally published in Clinica
Brazil is consulting on the creation and operation of a national human embryo register that will form the basis for the co-ordination and surveillance of therapeutic and research uses of all embryonic tissue. The plans proposed by healthcare regulatory agency Anvisa are that SisEmbrio be used to register all embryos surplus to IVF treatment and information on the tissues derived from them, including stem cells, for a period of 20 years. The handling of the embryos and the management and submission of their data to SisEmbrio will be the responsibility of the BCTG network of cell and regenerative tissue banks. The register will automatically generate a unique code for each embryo and record data on their subsequent use. Anvisa will be responsible for SisEmbrio. The 30-day consultation ends August 26.